Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Long QT Syndrome Now Observable with AI

By HospiMedica International staff writers
Posted on 23 May 2018
A new study reveals that artificial intelligence (AI) can successfully identify patients with congenital long QT syndrome (LQTS), despite having a normal QT interval on the standard electrocardiogram (ECG).

Researchers at the Mayo Clinic (Rochester, MN, USA) and AliveCor (San Francisco, CA, USA) conducted a retrospective study of 1,048 patients suffering from LQTS and a further 1,010 who were dismissed as such who had an ECG taken at the Mayo Genetic Heart Rhythm Clinic. More...
An AI deep neural network (DNN) involving a multilayer convolutional recurrent neural network (CRNN) was then used to classify patients using a 10 second ECG from lead 1 alone; 72% of the ECGs were used for training and 28% for validation.

The results revealed that the DNN employed in the study generated an area under the curve of 0.83, with a specificity of 81%, sensitivity of 73%, and an overall accuracy of 79%. It was able to distinguish between the three main genotypes (LQTS1, LQTS2, and LQTS3). In addition, the DNN could successfully identify patients with congenital LQTS despite having a normal QT interval on a standard ECG, which is the case in as many as 50% of patients. The study was presented at the 40th annual Heart Rhythm Scientific Sessions conference, held during May 2018 in Boston (MA, USA).

"Although long QT syndrome is a potentially lethal syndrome, when it is recognized and treated, sudden death should almost never happen," said senior author Michael Ackerman, MD, PhD, director of Mayo Clinic's LQTS/Genetic Heart Rhythm Clinic. “The expectation needs to shift from merely preventing sudden death to enabling these patients and their families to live and thrive despite the diagnosis. Hopefully, the results of this study should be reassuring and encouraging to these families who live with long QT syndrome.”

LQTS is a condition that affects abnormal repolarization of the heart after a heartbeat, resulting in an increased risk fainting, drowning, or sudden death. It may be present at birth or develop later in life as a result of medication, low blood potassium, low blood calcium, or heart failure (HF). Medications that are implicated include certain anti-arrhythmic, antibiotics, and antipsychotics. Diagnosis is based on an ECG finding of a corrected QT interval of greater than 440-500 milliseconds and clinical findings. For people with LQTS who survive cardiac arrest and remain untreated, the risk of death within 15 years is greater than 50%, but with proper treatment, this decreases to less than 1% over 20 years.

Related Links:
Mayo Clinic
AliveCor


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hybrid Arch Device
Neo EDE
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.